Filing Details
- Accession Number:
- 0001209191-11-027631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-11 16:53:00
- Reporting Period:
- 2011-05-10
- Filing Date:
- 2011-05-11
- Accepted Time:
- 2011-05-11 16:53:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333248 | Cadence Pharmaceuticals Inc | CADX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1466916 | A. Scott Byrd | C/O Cadence Pharmaceuticals, Inc. 12481 High Bluff Drive, Ste 200 San Diego CA 92130 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-10 | 2,000 | $7.22 | 2,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from a low of $7.21 to a high of $7.22. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
